A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma.
Wong BS, Shah SR, Yankaskas CL, Bajpai VK, Wu PH, Chin D, Ifemembi B, ReFaey K, Schiapparelli P, Zheng X, Martin SS, Fan CM, Quiñones-Hinojosa A, Konstantopoulos K.
Wong BS, et al. Among authors: zheng x.
Nat Biomed Eng. 2021 Jan;5(1):26-40. doi: 10.1038/s41551-020-00621-9. Epub 2020 Sep 28.
Nat Biomed Eng. 2021.
PMID: 32989283
Free PMC article.